The Power of Truth® has been released for sale and assignment to a conservative pro-American news outlet, cable network, or other media outlet that wants to define and brand its operation as the bearer of the truth, and set itself above the competition.

In every news story the audience hears of censorship, speech, and the truth. The Power of Truth® has significant value to define an outlet, and expand its audience. A growing media outlet may decide to rebrand their operation The Power of Truth®. An established outlet may choose to make it the slogan distinguishing their operation from the competition. You want people to think of your outlet when they hear it, and think of the slogan when they see your company name. It is the thing which answers the consumer's questions: Why should I choose you? Why should I listen to you? Think:

  • What’s in your wallet -- Capital One
  • The most trusted name in news – CNN
  • Fair and balanced - Fox News
  • Where’s the beef -- Wendy’s
  • You’re in good hands -- Allstate
  • The ultimate driving machine -- BMW

The Power of Truth® is registered at the federal trademark level in all applicable trademark classes, and the sale and assignment includes the applicable domain names. The buyer will have both the trademark and the domains so that it will control its business landscape without downrange interference.

Contact: Truth@ThePowerOfTruth.com

Thursday, September 19, 2024
Thursday, September 19, 2024

Farmers in sub-Saharan Africa need to diversify away from growing maize and switch to crops that are resilient to climate change and supply enough key micronutrients for the population, according to a major research study. Maize is a staple crop across the region -- where it is grown and consumed in vast quantities.
Read more …'Nutritional quality must be at the heart of climate smart agriculture' -- researchers

Aptamers, nucleic acids capable of selectively binding to viruses, proteins, ions, small molecules, and various other targets, are garnering attention in drug development as potential antibody substitutes for their thermal and chemical stability as well as ability to inhibit specific enzymes or target proteins through three-dimensional binding. They also hold promise for swift diagnoses of colon cancer and other challenging diseases by targeting elusive biomarkers. Despite their utility, these aptamers are susceptible to easy degradation by multiple enzymes, presenting a significant challenge.
Read more …Aptamers: lifesavers; ion shields: aptamer guardians

Just like a doctor adjusts the dose of a medication to the patient's needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window. Staying within the therapeutic window is important as too much of the protein could be toxic, and too little could result in a small or no therapeutic effect. Researchers now report on a technology to effectively regulate gene expression, a promising solution to fill this gap in gene therapy clinical applications.
Read more …A novel switch to turn genes on/off on cue, a promising step toward safer gene therapy

More Articles …

  1. Junior doctors strike: NHS chief warns of tough new year
  2. Almost three million tested for cancer in England
  3. Cancer: Almost three million tested in England
  4. Actress and mum get MBEs for brain charity work
  5. Revolutionary nanodrones enable targeted cancer treatment
  6. One dead following cheese recall over E. coli
Page 625 of 923